KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

GoodRx Holdings (GDRX) Deferred Taxes (2019 - 2025)

GoodRx Holdings (GDRX) has disclosed Deferred Taxes for 7 consecutive years, with $12.0 million as the latest value for Q4 2025.

  • Quarterly Deferred Taxes rose 206.3% to $12.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $68000.0 through Dec 2025, up 100.57% year-over-year, with the annual reading at $20.1 million for FY2025, 268.47% up from the prior year.
  • Deferred Taxes hit $12.0 million in Q4 2025 for GoodRx Holdings, up from -$11.3 million in the prior quarter.
  • In the past five years, Deferred Taxes ranged from a high of $46.1 million in Q4 2021 to a low of -$63.0 million in Q2 2023.
  • Historically, Deferred Taxes has averaged -$3.5 million across 5 years, with a median of -$227000.0 in 2021.
  • Biggest YoY gain for Deferred Taxes was 2459.49% in 2023; the steepest drop was 108746.55% in 2023.
  • Year by year, Deferred Taxes stood at $46.1 million in 2021, then tumbled by 100.77% to -$356000.0 in 2022, then crashed by 2027.25% to -$7.6 million in 2023, then crashed by 48.84% to -$11.3 million in 2024, then surged by 206.3% to $12.0 million in 2025.
  • Business Quant data shows Deferred Taxes for GDRX at $12.0 million in Q4 2025, -$11.3 million in Q4 2024, and -$642000.0 in Q3 2024.